Valeura Energy Inc (VLE):石油・ガス:M&Aディール及び事業提携情報

◆英語タイトル:Valeura Energy Inc (VLE) - Oil & Gas - Deals and Alliances Profile
◆商品コード:DATA904C8735
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:65
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:石油・ガス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Valeura Energy Inc (Valeura) is an upstream oil and gas company that explores for, develops and produces oil and natural gas. It operates mainly in the Thrace Basin in the northwest of Turkey pursuing conventional shallow natural gas, unconventional tight gas and a basin-centered gas accumulation (BCGA) play. The company has working interests in production leases and exploration licenses. Through its interests in a joint venture, Valeura owns and operates its own gas gathering grid and export lines to its regional customers. The company has subsidiaries in the Netherlands, British Virgin Islands and Turkey. Valeura is headquartered in Calgary, Alberta, Canada.

Valeura Energy Inc (VLE) – Oil & Gas – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Oil & Gas eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Valeura Energy Inc, Oil & Gas, Deals By Year, 2012 to YTD 2018 6
Valeura Energy Inc, Oil & Gas Deals By Type, 2012 to YTD 2018 7
Valeura Energy Inc, Oil & Gas, Deals By Region, 2012 to YTD 2018 8
Valeura Energy Inc, Oil & Gas, Deals By Sector, 2012 to YTD 2018 9
Valeura Energy Inc, Oil & Gas, Deals Summary, 2012 to YTD 2018 10
Valeura Energy Inc, Oil & Gas, Deal Details 11
Equity Offering 11
Valeura Completes Public Offering Of Shares For US$47.8 Million 11
Valeura Energy Completes Private Placement Of Subscription Receipts For US$8.3 Million 12
Valeura Energy Completes Public Offering Of Shares For US$15.4 Million 13
Asset Transactions 14
Statoil Completes Acquisition Of Additional 10% Stake In Deep Formations Rights On TBNG JV Lands In Turkey From Valeura Energy For US$3 Million 14
Statoil Completes Acquisition Of 40% Stake In Deep Formations Rights On TBNG JV Lands In Turkey From Valeura Energy For US$12 Million 15
Statoil Holding Completes Acquisition Of 50% Interest In Deep Formations On Banarli Licenses In Turkey From Valeura Energy 16
Valeura Energy Sells Nine Oil And Gas Properties In Alberta 18
Valeura Energy Sells 27.5% Interest In Two Karakilise Licenses In Southeast Turkey 19
Acquisition 20
Valeura Energy Completes Acquisition Of Thrace Basin Natural Gas From TransAtlantic Petroleum For US$20.9 Million 20
Valeura Energy Inc – Key Competitors 22
Valeura Energy Inc – Key Employees 23
Valeura Energy Inc – Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Recent Developments 25
Financial Announcements 25
Nov 14, 2017: Valeura Announces Third Quarter 2017 Financial And Operating Results And Commencement Of Yamalik-1 Testing Program 25
Aug 10, 2017: Valeura Announces Second Quarter 2017 Financial And Operating Results 29
May 10, 2017: Valeura Announces First Quarter 2017 Financial And Operating Results, Completion Of Transformational Transactions And Imminent Start Of Deep Drilling Operations 32
Other Significant Developments 35
Oct 09, 2018: Valeura announces start of deep appraisal drilling, further increase to Turkish gas prices 35
Sep 16, 2018: Valeura announces initial production rates from Yamalik-1 well long-term test 36
Sep 05, 2018: Valeura announces increased gas prices and operations update 37
Aug 08, 2018: Valeura announces second quarter 2018 results and restart of operations at Yamalik-1 38
Jul 31, 2018: Valeura announces increased natural gas prices 40
Jun 28, 2018: Valeura Provides Operations Update, Basin Centered Gas Accumulation Appraisal Program Begins 41
May 09, 2018: Valeura Announces First Quarter 2018 Results and Updates on Progress for Appraisal Activities 42
Apr 18, 2018: Valeura Announces Increased 2018 Natural Gas Prices, Lyle Martinson Appointed As Chief Operating Officer 44
Feb 06, 2018: Valeura Announces Prospective Resources For Unconventional Basin-Centered Gas Prospect 45
Jan 16, 2018: TransAtlantic Petroleum Announces Engagement Of Financial Advisor To Market Company And Provides Updates On Drilling Program & Prospects In Thrace Basin 47
Jan 15, 2018: Valeura Provides Operational Update and Announces Board Changes 48
Jan 02, 2018: Valeura Announces Completion Of CEO Succession Plan 51
Dec 27, 2017: Valeura reports production testing progress (Test 4) at Yamalik-1 well 52
Dec 18, 2017: Valeura reports production testing progress (Test 3) at Yamalik-1 Well 53
Dec 11, 2017: Valeura Updates Production Testing Progress At Yamalik-1 Well 54
Nov 27, 2017: Valeura Announces Positive Interim Production Test Results And Confirms Natural Gas And Condensate Discovery At Yamalik-1 Well 55
Oct 17, 2017: Valeura Announces Yamalik-1 Testing Program And Operational Update 56
Jul 24, 2017: Valeura Announces Rig Release From Yamalik-1 Well And Positive Evaluation Results 58
Jun 22, 2017: Valeura Announces Closing Of Subsequent West Thrace Deep Rights Sale To Statoil And Operational Update 59
May 17, 2017: Valeura Energy appoints COO 60
Mar 14, 2017: Valeura Energy Announces Fourth Quarter 2016 Financial And Operating Results And Year-End 2016 Reserves 61
Appendix 65
Methodology 65
About GlobalData 65
Contact Us 65
Disclaimer 65

List of Tables
Valeura Energy Inc, Oil & Gas, Key Facts, 2017 2
Valeura Energy Inc, Oil & Gas, Deals Summary, 2012 to YTD 2018 2
Valeura Energy Inc, Oil & Gas, Deals By Year, 2012 to YTD 2018 6
Valeura Energy Inc, Oil & Gas Deals By Type, 2012 to YTD 2018 7
Valeura Energy Inc, Oil & Gas, Deals By Region, 2012 to YTD 2018 8
Valeura Energy Inc, Deals By Sector, 2012 to YTD 2018 9
Valeura Energy Inc, Oil & Gas, Deals Summary, 2012 to YTD 2018 10
Valeura Completes Public Offering Of Shares For US$47.8 Million 11
Valeura Energy Completes Private Placement Of Subscription Receipts For US$8.3 Million 12
Valeura Energy Completes Public Offering Of Shares For US$15.4 Million 13
Statoil Completes Acquisition Of Additional 10% Stake In Deep Formations Rights On TBNG JV Lands In Turkey From Valeura Energy For US$3 Million 14
Statoil Completes Acquisition Of 40% Stake In Deep Formations Rights On TBNG JV Lands In Turkey From Valeura Energy For US$12 Million 15
Statoil Holding Completes Acquisition Of 50% Interest In Deep Formations On Banarli Licenses In Turkey From Valeura Energy 16
Valeura Energy Sells Nine Oil And Gas Properties In Alberta 18
Valeura Energy Sells 27.5% Interest In Two Karakilise Licenses In Southeast Turkey 19
Valeura Energy Completes Acquisition Of Thrace Basin Natural Gas From TransAtlantic Petroleum For US$20.9 Million 20
Valeura Energy Inc, Key Competitors 22
Valeura Energy Inc, Key Employees 23
Valeura Energy Inc, Other Locations 24
Valeura Energy Inc, Subsidiaries 24

List of Figures
Valeura Energy Inc, Oil & Gas, Deals by Type, 2012 to YTD 2018 2
Valeura Energy Inc, Oil & Gas, Deals By Year, 2012 to YTD 2018 2
Valeura Energy Inc, Oil & Gas, Deals By Region, 2012 to YTD 2018 2
Valeura Energy Inc, Oil & Gas, Deals By Sector, 2012 to YTD 2018 2
Valeura Energy Inc, Oil & Gas, Deals By Year, 2012 to YTD 2018 6
Valeura Energy Inc, Oil & Gas, Deals by Type, 2012 to YTD 2018 7
Valeura Energy Inc, Oil & Gas, Deals By Region, 2012 to YTD 2018 8
Valeura Energy Inc, Oil & Gas, Deals by Sector, 2012 to YTD 2018 9

★海外企業調査レポート[Valeura Energy Inc (VLE):石油・ガス:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Intra-Cellular Therapies Inc (ITCI):企業の財務・戦略的SWOT分析
    Summary Intra-Cellular Therapies Inc (ICTI) is a biopharmaceutical company. The company develops drugs for the treatment of neuropsychiatric and neurodegenerative diseases. Its pipeline products include lumateperone (ITI-007), used for the treatment of schizophrenia, behavioral disturbances associat …
  • Opsona Therapeutics Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Opsona Therapeutics Ltd (Opsona) is a drug developing company that conducts research, develops and commercializes new treatment for the autoimmune and inflammatory diseases and cancers. The company's OPN-305 is a humanized antibody used to reduce pro-inflammatory cytokine production that is …
  • Anika Therapeutics Inc (ANIK):企業の財務・戦略的SWOT分析
    Anika Therapeutics Inc (ANIK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Senhwa Biosciences Inc (6492)-製薬・医療分野:企業M&A・提携分析
    Summary Senhwa Biosciences Inc (Senhwa) is a drug development company that develops small molecule drugs for the treatment of cancer. The company’s products include CX-5461 and CX-4945. Its CX-5461 is a p53 activating Pol I inhibitor and anticancer compound for treating hematological malignancies. S …
  • Polaris Industries Inc (PII):企業の財務・戦略的SWOT分析
    Polaris Industries Inc (PII) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Bankers Insurance Group:企業の戦略・SWOT・財務情報
    Bankers Insurance Group - Strategy, SWOT and Corporate Finance Report Summary Bankers Insurance Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Diageo plc:企業の戦略・SWOT・財務情報
    Diageo plc - Strategy, SWOT and Corporate Finance Report Summary Diageo plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • McConnell Dowell Corp Ltd:企業の戦略的SWOT分析
    McConnell Dowell Corp Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Yext, Inc. (YEXT):企業の財務・戦略的SWOT分析
    Yext, Inc. (YEXT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • MAN SE:企業の戦略・SWOT・財務情報
    MAN SE - Strategy, SWOT and Corporate Finance Report Summary MAN SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • Sunbelt Rentals Inc:企業のM&A・事業提携・投資動向
    Sunbelt Rentals Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Sunbelt Rentals Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Vietnam Export Import Commercial Joint Stock Bank
    Vietnam Export Import Commercial Joint Stock Bank - Strategy, SWOT and Corporate Finance Report Summary Vietnam Export Import Commercial Joint Stock Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structur …
  • NovaBay Pharmaceuticals Inc (NBY)-製薬・医療分野:企業M&A・提携分析
    Summary NovaBay Pharmaceuticals Inc (NovaBay), formerly NovaCal Pharmaceuticals Inc is a biopharmaceutical company that develops eyecare products. The company’s products include daily lid and lash hygiene spray solution, skin and wound cleanser, and cosetic procedures. Its daily lid and lash hygiene …
  • Northern Technologies International Corp (NTIC):企業の財務・戦略的SWOT分析
    Northern Technologies International Corp (NTIC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key st …
  • Medistim ASA (MEDI):企業の財務・戦略的SWOT分析
    Summary MediStim ASA (MediStim) is a medical device company that manufactures and markets medical products for cardiac, vascular and transplant surgeries. The company’s products include MiraQ cardiac, MiraQ vascular, MiraQ ultimate system, imaging probes, flow probes, VeriQ C and VeriQ systems. Its …
  • Luxair S.A.:企業の戦略・SWOT・財務情報
    Luxair S.A. - Strategy, SWOT and Corporate Finance Report Summary Luxair S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • AstraZeneca Plc (AZN)-製薬・医療分野:企業M&A・提携分析
    Summary AstraZeneca plc (AstraZeneca) is a biopharmaceutical company that endeavors to discover, produce and commercialize a wide range of prescription drugs. It focuses on therapy areas such as respiratory; cardiovascular and metabolic disease (CVMD); and cancer, besides autoimmune, infection and n …
  • Civica Group Limited:企業の戦略的SWOT分析
    Civica Group Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Alliant Energy Corp (LNT):企業の財務・戦略的SWOT分析
    Alliant Energy Corp (LNT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Asahi Kasei Pharma Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary Asahi Kasei Pharma Corp (Asahi Kasei Pharma), a subsidiary of Asahi Kasei Corp, discovers, develops, manufactures, and markets pharmaceuticals and diagnostic products. The company's portfolio encompasses prescription drugs, diagnostic reagents, and enzymes for diagnostic reagents. Its prescr …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆